Impax to Sell Generic Renvela, Renagel in 2014 After Genzyme Settlement

Washington Drug Letter
A A
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00